Pharmaceutical Omega-3 API Market

Pharmaceutical omega-3 API sales will grow through 2036, led by marine fish oil-derived APIs at 81.3% share in 2026. Ethyl ester concentrates hold 64.2% and DMF and CEP-supported APIs account for 58.4%. The market is sized at USD 1.1 billion in 2026 and USD 2.3 billion by 2036.